Literature DB >> 25172380

Calorie restriction aggravated cortical and trabecular bone architecture in ovariectomy-induced estrogen-deficient rats.

Hyejin Ahn1, Dong-Hyun Seo2, Han Sung Kim2, Ryowon Choue3.   

Abstract

We hypothesized that calorie restriction (CR) and estrogen deficiency (ovariectomy [OVX]) would aggravate bone biomarkers and structural parameters in rats. Seven-week-old female Sprague-Dawley rats were randomized to sham-operated groups and fed either an ad libitum diet (SHAM-AL) or a CR diet (SHAM-CR); ovariectomy-operated groups were fed an ad libitum diet (OVX-AL) or a CR diet (OVX-CR). For 8 weeks, the OVX-AL and SHAM-AL groups were fed the same diet, whereas CR groups were fed a diet containing 50% fewer calories. Bone-related biomarkers and structural parameters (OC; deoxypyridinoline [DPD]; N-terminal telopeptide, NTx; architecture and mineralization; and microcomputed tomography images) were analyzed at the end of the experiment. The serum OC levels of calorie-restricted groups (SHAM-CR and OVX-CR) were significantly lower than those of the AL groups (SHAM-AL and OVX-AL) (P < .05). Urinary DPD levels of calorie-restricted and ovariectomized groups were higher than those of their counterparts (P < .05), whereas urinary NTx levels of calorie-restricted groups were higher than those of AL groups (P < .05). In regard to trabecular bone, the calorie-restricted and ovariectomized groups had lower values of bone volume to total volume, trabecular number, and bone mineral density, but higher values of trabecular separation than those of their counterparts (P < .05). Regarding cortical bone, the calorie-restricted groups had reduced values of bone volume, mean polar moment of inertia, and cortical thickness compared to the AL groups (P < .05). In conclusion, severe CR with or without OVX during the growth period in rats is equally detrimental to bone; CR has detrimental effects on trabecular and cortical bone; and estrogen deficiency only had an effect on trabecular bone.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Calorie restriction; Estrogen deficiency; Ovariectomy; Rat

Mesh:

Substances:

Year:  2014        PMID: 25172380     DOI: 10.1016/j.nutres.2014.07.006

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  5 in total

1.  Bone Mineral Density and Cognitive Decline in Elderly Women: Results from the InCHIANTI Study.

Authors:  Alice Laudisio; Davide Onofrio Fontana; Chiara Rivera; Carmelinda Ruggiero; Stefania Bandinelli; Antonella Gemma; Luigi Ferrucci; Raffaele Antonelli Incalzi
Journal:  Calcif Tissue Int       Date:  2015-12-28       Impact factor: 4.333

2.  Pycnogenol(®) treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats.

Authors:  Gangyong Huang; Jianguo Wu; Siqun Wang; Yibing Wei; Feiyan Chen; Jie Chen; Jingsheng Shi; Jun Xia
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Effects of Biliopancreatic Diversion on Bone Turnover Markers and Association with Hormonal Factors in Patients with Severe Obesity.

Authors:  Anne-Frédérique Turcotte; Thomas Grenier-Larouche; Roth-Visal Ung; David Simonyan; Anne-Marie Carreau; André C Carpentier; Fabrice Mac-Way; Laetitia Michou; André Tchernof; Laurent Biertho; Stefane Lebel; Simon Marceau; Claudia Gagnon
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

4.  Soy protein improves tibial whole-bone and tissue-level biomechanical properties in ovariectomized and ovary-intact, low-fit female rats.

Authors:  Pamela S Hinton; Laura C Ortinau; Rebecca K Dirkes; Emily L Shaw; Matthew W Richard; Terese Z Zidon; Steven L Britton; Lauren G Koch; Victoria J Vieira-Potter
Journal:  Bone Rep       Date:  2018-05-18

5.  Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.

Authors:  David E Maridas; Elizabeth Rendina-Ruedy; Ron C Helderman; Victoria E DeMambro; Daniel Brooks; Anyonya R Guntur; Beate Lanske; Mary L Bouxsein; Clifford J Rosen
Journal:  FASEB J       Date:  2018-10-24       Impact factor: 5.834

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.